[Secondary carnitine deficiency].
Yorifuji
S
S
Department of Laboratory Science, School of Allied Health Sciences, Faculty of Medicine, Osaka University.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D019735:Carbon-Carbon Ligases / Q000172:deficiency; D002331:Carnitine / Q000172:deficiency* / Q000378:metabolism; D002334:Carnitine O-Palmitoyltransferase / Q000172:deficiency; D002352:Carrier Proteins / Q000037:antagonists & inhibitors; D003937:Diagnosis, Differential; D006801:Humans; D007769:Lactams; D027701:Organic Cation Transport Proteins; D011379:Prognosis; D000074058:Solute Carrier Family 22 Member 5; D014635:Valproic Acid / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D002352:Carrier Proteins; D007769:Lactams; D027701:Organic Cation Transport Proteins; C492020:SLC22A5 protein, human; D000074058:Solute Carrier Family 22 Member 5; D014635:Valproic Acid; D002334:Carnitine O-Palmitoyltransferase; D019735:Carbon-Carbon Ligases; C021573:methylcrotonoyl-CoA carboxylase; D002331:Carnitine